According to the report by Expert Market Research, the Vietnam Vaccine Market attained a value of USD 3.93 billion in 2025, and is expected to reach USD 9.83 billion by 2035, growing at a CAGR of 9.6%. The demand for vaccines is driven by factors such as increasing awareness about vaccination, government initiatives to promote vaccination, and advancements in vaccine technology. The long-term strategic importance of this market lies in its potential to improve public health and prevent the spread of diseases.The current supply-demand conditions in the vietnam vaccine market are characterized by a shortage of certain types of vaccines, leading to a surge in demand for alternative products. A notable consumer behaviour shift is the increasing preference for multivalent vaccines, which offer protection against multiple diseases. For instance, producers are responding to this trend by developing new multivalent vaccines, such as those that combine protection against viral and bacterial diseases. This shift is also driven by the growing awareness about the importance of vaccination among parents and healthcare professionals.
Request your complimentary sample report featuring the complete TOC
www.expertmarketresearch.com/reports/vietnam-vaccine-market/requestsample
The government has initiated several policies to promote the development and distribution of vaccines, including tax incentives for vaccine manufacturers and investments in public health infrastructure. These initiatives have led to an increase in the production and availability of vaccines, particularly in rural areas. The regulatory framework for vaccine approval has also been streamlined, allowing for faster introduction of new vaccines to the market.
A significant technology advancement that is reshaping the production of vaccines is the development of mRNA vaccine technology. This technology is still in its early adoption stage, but it has the potential to revolutionize the vaccine industry by allowing for faster and more efficient production of vaccines. Companies such as Pfizer Inc. and Moderna are leading the development of this technology, which is expected to have a significant impact on pricing, efficiency, and product quality. As a result, companies that adopt this technology are likely to gain a competitive advantage in the market.
The vietnam vaccine market can be segmented by product type, type, route of administration, disease indication, age, and end user. Major players such as Sanofi, GlaxoSmithKline plc, and AstraZeneca plc are competing for market share in these segments. The segmentation of the market is influencing market positioning and pricing strategy, with companies targeting specific segments with tailored products and pricing.
Looking ahead, the strongest growth catalyst for the period through 2035 is expected to be the increasing demand for vaccines driven by government initiatives and advancements in technology. However, a realistic risk that could moderate growth pace is the potential for supply chain disruptions due to geopolitical tensions. Despite this risk, companies such as Johnson & Johnson Services, Inc. are well-positioned to capitalize on the growth opportunities in the market, and the vietnam vaccine market is expected to continue to grow and evolve in the coming years.